製品名:2,6-Dichloro-5-fluoronicotinamide

IUPAC Name:2,6-dichloro-5-fluoropyridine-3-carboxamide

CAS番号:113237-20-0
分子式:C6H3Cl2FN2O
純度:98%
カタログ番号:CM178393
分子量:209

包装単位 有効在庫 価格(USD) 数量
CM178393-500g in stock ȋƅdž
CM178393-1000g in stock şœǺ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:113237-20-0
分子式:C6H3Cl2FN2O
融点:-
SMILESコード:O=C(N)C1=C(Cl)N=C(Cl)C(F)=C1
密度:
カタログ番号:CM178393
分子量:209
沸点:
MDL番号:MFCD01571365
保管方法:Store at room temperature

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

Sotorasib
Dec. 26, 2023, Amgen announced that the U.S. FDA has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).
LUMAKRAS (sotorasib) is an oral, first-in-class therapy indicawithted for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) following at least one previous systemic therapy.
Sotorasib is the first approved targeted therapy for patients with tumors with any KRAS mutation, which accounts for approximately 25% of mutations in NSCLC. The U.S. FDA granted the application for sotorasib orphan drug, fast track, priority review, and breakthrough therapy designations.

Related Products